Orfit to Feature Radiation Oncology at Conference of American Association of Physicists in Medicine Conference
Live demonstrations of Sagittilt Prone Breast Solution, SBRT Solution and High-Precision Hybrid Open Face Mask to be held during event
JERICHO, N.Y., July 8, 2014 /PRNewswire/ -- Orfit Industries America, North American subsidiary of Orfit Industries, today announced it will showcase the Sagittilt Prone Breast Solution, SBRT Solution and High Precision Hybrid Open Face Mask at the American Association of Physicists (AAPM) Conference in Austin, Texas, July 20-24 (Booth 932). Orfit Industries is a world leader in the development, and manufacture of low temperature thermoplastics, hardware and accessories for patient immobilization and positioning in radiation oncology.
AAPM is a scientific, educational, and professional organization of more than 8,000 medical physicists and is headquartered at the American Center for Physics in College Park, Md. Publications include a scientific journal ("Medical Physics"), technical reports, and symposium proceedings.
The Sagittilt™ Prone Breast Solution is an innovative positioning and immobilization system that accurately sets-up and reproduces the prone position of a breast patient during simulation and treatment. Sagittilt is unique in that the patient can be tilted up to 10˚ in increments of 1˚ to let the ipsi-lateral breast fall deeper into the cut-out and further away from the organs at risk, such as heart and lung. Only one person is needed to perform the tilting. To increase comfort, the position of the arms, elbows, legs forehead is adjustable to the patient's anatomy. Once set the patient positions are indexed to ensure reproducibility.
The Orfit SBRT Solution provides users with the precision, stability, reproducibility and ease of use required for treatment of abdominal and lung tumors. Unmatched positioning flexibility and high patient comfort are hallmarks of this lightweight fully MRI Compatible system. It is supplied with a mechanical or pneumatic abdominal pressure system and a full arrange of adjustable compression arches and accessories designed to facilitate treatment and ensure patient comfort. A unique quick release patient safety mechanism immediately unlocks the compression screw in the event it is necessary.
The High Precision Hybrid Open Face Mask has been designed to optimize patient comfort during radiation therapy of the head and neck, while enabling better reproducibility and, in many cases, higher-precision treatment than standard head and neck masks. The Open Face Hybrid Mask leaves most of the face uncovered, thereby reducing the often significant discomfort and anxiety experienced by patients undergoing radiation therapy. Reinforced with Orfit's proprietary thermoplastic materials, the new mask is also thinner and lighter than standard masks, while ensuring maximum horizontal and rotational stability. Like all thermoplastic materials made by Orfit, it is easy to mold and use, providing excellent reproducibility.
About Orfit Industries
A family-owned business headquartered in Antwerp, Belgium, Orfit Industries is a market leader in the development and manufacturing of low temperature thermoplastics, hardware and accessories for patient immobilization and positioning in radiation oncology. With exports to more than 100 countries worldwide, the company also manufactures thermoplastic materials for the physical rehabilitation and technical orthopedics markets, such as splints and prostheses. In addition to Orfit Industries America, its North American subsidiary based in Jericho, New York, Orfit has subsidiaries in Germany, France and Hong Kong and a joint venture in Brazil. www.orfit.com
Follow Orfit online
http://www.orfit.com
http://blog.orfit.com
http://www.facebook.com/orfit.industries
http://www.twitter.com/orfit
http://www.linkedin.com/company/orfit-industries
http://www.youtube.com/OrfitIndustries
SOURCE Orfit Industries
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article